Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A

Gebonden Engels 2023 9780443161346
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

"Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast, prostate, colorectal and lung cancer, with a focus on clinical utility, and also include methodological and biological topics such as CTC culture, multi-omic characterization of CTCs, atypical CTC populations and interaction between CTCs and immunity.

Specificaties

ISBN13:9780443161346
Taal:Engels
Bindwijze:Gebonden

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

<p>1. Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer<br>Laura S. Munoz-Arcos, Eleonora Nicolò, Mara S. Serafini, Lorenzo Gerratana, Carolina Reduzzi, and Massimo Cristofanilli<br>2. Can we define breast cancer HER2 status of by liquid biopsy?<br>Serena Di Cosimo, Cinzia De Marco, Marco Silvestri, Adele Busico, Andrea Vingiani, Giancarlo Pruneri, and Vera Cappelletti<br>3. Models to study CTCs and CTC culture methods<br>Cristóbal Fernández-Santiago, Rafael López-López, and Roberto Piñeiro Cid<br>4. Settling the uncertainty about unconventional circulating tumor cells: epithelial-to-mesenchymal transition, cell fusion and trogocytosis<br>Giulia Gallerani, Tania Rossi, Manuela Ferracin, and Massimiliano Bonafè<br>5. Circulating tumor cells in cancer-risk populations as a cancer interception tool<br>María José Serrano, Christian Rolfo, José Expósito-Hernandez, Carmen Garrido-Navas, José Javier Lopez-Hidalgo, and Valeria Denninghoff<br>6. Circulating tumor cells and host immunity: a tricky liaison<br>Elena Muraro and Giulia Brisotto</p>

Managementboek Top 100

Rubrieken

    Personen

      Trefwoorden

        Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A